###begin article-title 0
Colocalization of Interferon Regulatory Factor 7 (IRF7) with Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
###end article-title 0
###begin p 1
###xml 195 213 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 215 218 <span type="species:ncbi:10376">EBV</span>
###xml 244 247 <span type="species:ncbi:10376">EBV</span>
###xml 424 427 <span type="species:ncbi:10376">EBV</span>
###xml 509 512 <span type="species:ncbi:10376">EBV</span>
###xml 534 537 <span type="species:ncbi:10376">EBV</span>
###xml 630 633 <span type="species:ncbi:10376">EBV</span>
###xml 945 948 <span type="species:ncbi:10376">EBV</span>
Interferon regulatory factor 7 (IRF7) is one of the transcriptional factors for the activation of type I Interferon (IFN) genes. It is known that IRF7 and the latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) are highly expressed in EBV type III latency cells, and LMP1 induces mRNA expression of IRF7. In this study, the expression pattern of endogenous IRF7 was observed in several B cell lines with or without EBV infection by immunofluorescence staining. IRF7 was localized in the cytoplasm of EBV-negative B cells and EBV type I latency B cell lines. However, IRF7 was located both in the cytoplasm and nucleus of EBV type III latency cell lines. In the Jijoye cell (type III latency cell), IRF7 was colocalized with LMP1 in the cytoplasm in a capping configuration, and their interaction was confirmed by co-immunoprecipitation of LMP1 and IRF7. This colocalization was confirmed by co-transfection of IRF7 and LMP1 plasmids in EBV-negative B cells. These results suggest that the IRF7 and LMP1 interact with each other, and this may relate to the mechanism whereby LMP1 exerts functional effects in B-lymphocytes.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 769 770 769 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 771 772 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 973 974 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
###xml 112 115 <span type="species:ncbi:10376">EBV</span>
###xml 714 717 <span type="species:ncbi:10376">EBV</span>
Epstein-Barr virus (EBV) immortalizes human B-lymphocytes in vitro; and latent membrane protein 1 (LMP1) of the EBV is essential for this process (1). LMP1 is a membrane protein composed of a short cytoplasmic amino-terminus linked to a transmembrane domain, with six membrane-spanning segments connected with short turns, and a long cytoplasmic carboxy-terminal domain (2). The six transmembrane domains of LMP1 play an important role for the aggregation of LMP1 and in forming a patch, which is essential for the activation of the signaling pathway (3). LMP1 associates with vimentin and other cellular proteins, forming a patch in the lymphocyte plasma membrane. LMP1 also colocalizes with the LMP2A protein of EBV, which recruits cellular protein tyrosine kinases (4,5). Biological effects of LMP1, such as induction of several cellular genes, are mediated by the activation of several signaling pathway, such as NF-kappaB, p38/MAPK, Jak/STAT, JNK/AP-1, PI3K/Akt etc. (6).
###end p 3
###begin p 4
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 756 758 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 759 761 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 891 893 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 894 896 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1097 1099 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Interferon regulatory factors (IRFs) are a growing family of transcriptional factors that share homology within the amino-terminal DNA binding domain (115 amino acids) (7). They are implicated in several biological processes, such as antiviral defense, cytokine signaling, cell growth, differentiation, oncogenesis and apoptosis (8-11). Two members of IRF family, IRF3 and IRF7, are considered to be important factors for the expression of type I interferon (IFN) genes following viral infection (12). IRF3 is constitutively expressed in a variety of cells and tissues (9), but IRF7 is expressed predominantly in lymphoid cells (13,14). IRF7 locates in the cytoplasm and translocates to the nucleus after virus infection, via phosphorylation by IKKepsilon(14-16). Recently, it was found that IRF7 and LMP1 induce each other within a regulatory circuit and IRF5 brakes the IRF7/LMP1 circuit (17,20). IRF7 can induce expression of LMP1 by binding to the IFN-stimulated response element (ISRE) of the LMP1 promoter, but the mechanism of induction and phosphorylation of IRF7 by LMP1 was unknown yet (19). LMP1 protein is a membranes protein and LMP1 cannot bind to the IRF7 promoter directly. Therefore, the interaction between LMP1 and IRF7 or other mediators might need for the regulation of IRF7 expression by LMP1.
###end p 4
###begin p 5
Thus, this study was designed to determine the localization of endogenous IRF7 and the physical interaction of IRF7 with LMP1 in B lymphoblastoid cell lines.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Cell lines and cell culture
###end title 7
###begin p 8
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 100 106 <span type="species:ncbi:9913">bovine</span>
###xml 165 168 <span type="species:ncbi:10376">EBV</span>
###xml 244 247 <span type="species:ncbi:10376">EBV</span>
###xml 314 317 <span type="species:ncbi:10376">EBV</span>
All the cell lines used in this experiment were maintained in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics (Gibco-BRL, CA, U.S.A.). DG75 is an EBV-negative Burkitt's lymphoma cell line (21). Akata and Sav I cell lines are EBV-positive type I latency B cell lines (22). Jijoye and Sav III are EBV-positive type III latency B cell lines (23,24).
###end p 8
###begin title 9
Plasmids
###end title 9
###begin p 10
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
The expression vector used in this study is pcDNA3. The LMP1 expression plasmid, pcLMP1 (a gift from Tomakazu Yoshizaki), the IRF7 expression plasmid, pcIRF7 (13), and FLAG-tagged LMP1 wild-type (WT), (a gift from Nancy Raab-Traub), were used for transient transfection.
###end p 10
###begin title 11
Transfection
###end title 11
###begin p 12
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
DG75 cells were transfected with pcDNA3, pcIRF7, or FLAG-tagged wild type LMP1. 1x107 cells in 0.5 mL medium were pulsed once at 320 V, 975 microF capacitance in a 0.4 cm cuvette in Gene Pulse II (Bio-Rad, Hercules, CA, U.S.A.) with a total of 10 microg of DNA plasmids. Cells were harvested 48 hr after transfection and used for immunofluorescence assay, Western blot and co-immunoprecipitation.
###end p 12
###begin title 13
Antibodies
###end title 13
###begin p 14
###xml 5 8 <span type="species:ncbi:10376">EBV</span>
###xml 208 213 <span type="species:ncbi:10090">mouse</span>
###xml 227 233 <span type="species:ncbi:9986">rabbit</span>
###xml 268 273 <span type="species:ncbi:10090">mouse</span>
###xml 423 429 <span type="species:ncbi:9793">Donkey</span>
###xml 435 441 <span type="species:ncbi:9986">rabbit</span>
###xml 448 454 <span type="species:ncbi:9793">donkey</span>
###xml 460 465 <span type="species:ncbi:10090">mouse</span>
Anti-EBV LMP CS1-4 clone (DAKO, Denmark), anti-IRF7 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.), and anti-M2 Flag antibody (Sigma, St. Louis, MO, U.S.A.) were used as primary antibodies. Anti-mouse Ig-HRP, anti-rabbit Ig-HRP (Amersham, U.K.), and anti-mouse kappa-HRP (Southern Biotechnology Associates, Birmingham, AL, U.S.A.) were used as the secondary antibodies for Western blot or immunoprecipitation. Donkey anti-rabbit-FITC, donkey anti-mouse-rhodamine (Jackson ImmunoResearch Laboratory, West grove, PA, U.S.A.) were used as the secondary antibodies for immunofluorescence assay.
###end p 14
###begin title 15
Immunofluorescence assay
###end title 15
###begin p 16
###xml 276 282 <span type="species:ncbi:9793">donkey</span>
###xml 399 402 <span type="species:ncbi:10376">EBV</span>
###xml 488 494 <span type="species:ncbi:9793">donkey</span>
Jijoye and transfected DG75 cells were harvested and washed twice in phosphate-buffered saline (PBS). The cells were smeared on the HTC well slides (Cel-line, Portmouth, NH, U.S.A.) and air-dried. Cells were fixed with cold acetone for 10 min, and then blocked with 5% normal donkey serum (Jackson Laboratory, PA, U.S.A.) for 30 min at 37℃. Primary antibodies were incubated for 90 min at 37℃. Anti-EBV LMP CS1-4 clone and anti-IRF7 antibody were diluted 1:50 in PBS containing 2% normal donkey serum. Slides were washed three times with PBS. Secondary antibodies were diluted 1:100 in PBS and incubated for 45 min at 37℃. After washing with PBS, they were mounted using Vector-shield (Vector Laboratory, Burlingame, CA, U.S.A.), and then examined with the Axioscope fluorescence microscope (Zeiss, Germany) or the TCS-NT confocal microscope (Leica, Germany). The images were captured using a Scion software program.
###end p 16
###begin title 17
Co-immunoprecipitation
###end title 17
###begin p 18
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
Jijoye cells (4x107 cells per immunoprecipitation) were washed in cold PBS twice and then lysed in 900 microL of lysis buffer (20 mM HEPES, 0.5% Nonidet P-40 [NP-40], 250 mM NaCl, 10% glycerol, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride [PMSF], sodium-orthovanadate, sodium fluoride, 1 tablet of complete [Amersham]) for 20 min at 4℃. The supernatant was clarified by centrifugation for 15 min at 4℃. IRF7 and LMP1 proteins were immunopurified with 20 microL of anti-IRF7 antibody with 100 microL of protein A Sepharose (Sigma) or 20 microL anti-LMP1 antibody with 100 microL of protein G Sepharose (Sigma), respectively, for overnight incubation with constant rocking at 4℃. For DG75 cells, cell lysates were immunopurified with 100 microL of anti-FLAG M2 agarose affinity gel (Sigma) for >4 hr with constant rocking at 4℃, or with 20 microL of anti-IRF7 antibody with 100 microL protein A Sepharose for overnight incubation with constant rocking at 4℃. Immunocomplexes were washed 4 times in lysis buffer, diluted in 2xsodium dodecyl sulfate (SDS) sample buffer, boiled for 5 min and then run on 10% SDS-polyacrylamide gel. LMP1 and IRF7 proteins were detected by immunoblotting as described below.
###end p 18
###begin title 19
Immunoblot analysis
###end title 19
###begin p 20
###xml 532 543 <span type="species:ncbi:3704">horseradish</span>
Immunoprecipitated samples separated on SDS-PAGE were transferred to nitrocellulose membranes using a semidry transfer apparatus. The membranes were blocked in PBS containing 10% nonfat dry milk and then probed with anti-IRF7 monoclonal antibody (1:50 dilution), anti-M2 flag antibody (1:500 dilution) in an overnight incubation at 4℃, or with anti-LMP1 monoclonal antibody (1:50 dilution) for 2 hr at room temperature (RT). The membranes were then washed three times with PBS containing 0.1% Tween 20, incubated with corresponding horseradish peroxidase (HRP)-linked secondary antibodies for 1 hr at RT, and reactivity was detected using a chemiluminescence reagent (Pierce, Rockford, IL, U.S.A.).
###end p 20
###begin title 21
RESULTS
###end title 21
###begin title 22
Localization of IRF7 protein in various B cell lines
###end title 22
###begin p 23
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 284 294 284 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B, C</xref>
###xml 411 418 411 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1D</xref>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1E</xref>
###xml 609 616 609 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1F</xref>
###xml 217 220 <span type="species:ncbi:10376">EBV</span>
###xml 244 247 <span type="species:ncbi:10376">EBV</span>
###xml 487 490 <span type="species:ncbi:10376">EBV</span>
DG75, Akata, Sav I, Sav III, and Jijoye cell lines were used for the immunofluorescence staining to confirm the localization of endogenous IRF7 protein. Immunoreactivity for IRF7 is shown as small bright spots in the EBV-negative (Fig. 1A) and EBV-positive type I latency cell lines (Fig. 1B, C). However, the IRF7 distributes as scattered granules throughout the entire cell of type III latency Sav III cells (Fig. 1D). There were two patterns of IRF7 in Jijoye, one identical with the EBV negative or type I latency cell line (Fig. 1E), and the other consists of clumps and scattered granules in the cells (Fig. 1F).
###end p 23
###begin title 24
###xml 28 31 <span type="species:ncbi:10376">EBV</span>
Colocalization of IRF7 with EBV LMP1 protein
###end title 24
###begin p 25
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 336 346 336 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A, B</xref>
###xml 403 410 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2C</xref>
###xml 563 570 563 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2D</xref>
To verify the localization of LMP1 and IRF7 proteins, double immunofluorescence was performed in Jijoye and Sav III cells, which express endogenous LMP1 and IRF7. The pattern of LMP1 immunofluorescence was identical with previous reports (2,6) and IRF7 colocalized with LMP1 as a capping configuration in the cytoplasm of Jijoye cells (Fig. 2A, B). There was only weak co-localization in Sav III cells (Fig. 2C). DG75 cells were transiently co-transfected with LMP1 and IRF7 plasmids and these are colocalized in DG75 cells, which expresses both of the proteins (Fig. 2D).
###end p 25
###begin title 26
LMP1 and IRF7 are co-immunoprecipitated in Jijoye cell and DG75 transfected with LMP1 and IRF7
###end title 26
###begin p 27
###xml 314 320 314 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 442 448 442 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 479 485 479 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 947 954 947 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4A</xref>
###xml 1022 1029 1022 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4A</xref>
###xml 1091 1098 1091 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4B</xref>
###xml 1168 1175 1168 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4B</xref>
###xml 1205 1212 1205 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4B</xref>
###xml 821 827 <span type="species:ncbi:9986">rabbit</span>
To confirm the physical interaction of the endogenous LMP1 and IRF7 proteins, co-immunoprecipitation was performed in the Jijoye cell. LMP1 and IRF7 were immunopurified with monoclonal CS1-4 antibody or anti-IRF7 antibody, and the immune complexes were subjected to SDS-PAGE and then analyzed by Western blotting (Fig. 3). Both LMP1 and IRF7 were detected by Western blot in the immunocomplexes, which were immunopurified with LMP1 antibody (Fig. 3, lane 1-2), or IRF7 antibody (Fig. 3, lanes 3-4). This result suggests that endogenous LMP1 and IRF7 interact with each other in the Jijoye cell. FLAG-LMP1 (WT), IRF7, or both of FLAG-LMP1 (WT) and IRF7 were over-expressed in DG75 cells by electroporation using Gene Pulser II, followed by co-immunoprecipitation. Cell lysates were immunopurified with M2 flag antibody or rabbit polyclonal IRF7 antibody. LMP1 and IRF7 were detected in the immune complex, which was purified with M2 flag antibody (Fig. 4A), the cell lysate that was co-transfected with both LMP1 and IRF7 (Fig. 4A, lane 4). In the immune complex purified with IRF7 antibody (Fig. 4B), LMP1 was detected in both cell lysates transfected with LMP1 only (Fig. 4B, lane 2), or LMP1 plus IRF7 (Fig. 4B, lane 4).
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 202 205 <span type="species:ncbi:10376">EBV</span>
IRF7 is a member of the interferon regulatory factor family. It is predominantly expressed in cells of lymphoid origin (13,14). IRF7 was first identified as a repressor of the Bam HI Q promoter (Qp) of EBV, which is used for the transcription of the Epstein-Barr nuclear antigen 1 (EBNA1) mRNA in type I latency cells (13). It is known that IRF7 and IRF3 are important for the induction of type I IFN gene expression following viral infection, and that IRF7 gene expression is induced by both type I IFN and by viral infection (12,14,25,26). As with IRF3, it is considered that the un-phosphorylated IRF7 (inactive form) locates in the cell cytoplasm and the phosphorylated IRF7 (active form) translocates to the nucleus (14,15). However, another report suggests that un-phosphorylated IRF7 is present in both the cytoplasm and the nucleus (27). In all of these previous experiments, the over-expression systems of IRF7 fusion proteins were used for the localization of IRF7. As mentioned in a recent paper concerning the half-life of IRF7 (18), there is a possibility that over-expressed IRF7 fusion proteins might differ from endogenous IRF7.
###end p 29
###begin p 30
###xml 353 359 353 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 512 521 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A-C</xref>
###xml 577 587 577 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1D, F</xref>
###xml 394 397 <span type="species:ncbi:10376">EBV</span>
To confirm the localization of endogenous IRF7, we applied immunofluorescent staining to several B-lymphoblastoid cell lines. There are two visual patterns of endogenous IRF7, one of tiny spots within a large granule located in the cytoplasm near the nuclear indentation, and the other of scattered granules in the nucleus with clumps in the cytoplasm (Fig. 1). The former pattern was found in EBV-negative and type I latency B-lymphoblastoid cell lines and is considered to represent an inactive state of IRF7 (Fig. 1A-C). The latter pattern was found in type III cell lines (Fig. 1D, F) and considered to represent an active state of IRF7.
###end p 30
###begin p 31
###xml 108 117 108 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A-C</xref>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1D</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 321 331 321 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1E, F</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1069 1070 1069 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1450 1452 1450 1452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 47 50 <span type="species:ncbi:10376">EBV</span>
###xml 547 550 <span type="species:ncbi:10376">EBV</span>
###xml 1354 1357 <span type="species:ncbi:10376">EBV</span>
The expression of IRF7 protein was very low in EBV-negative and type I latency B-lymphoblastoid cell lines (Fig. 1A-C), but it was high in the Sav III cell line (Fig. 1D). These results are in agreement with a previous Western blot results (13). In Jijoye a type III latency cell line, both of these patterns were found (Fig. 1E, F), and Raji (a type III latency lymphoblastoid cell line) also showed two patterns of IRF7 similar to those found in Jijoye cells (data not shown). There was evidence that LMP1 and IRF7 have a strong relationship in EBV-positive B cell lines (13,17,19). In type I latency, LMP1 is not expressed and IRF7 expression is very low, but the expression of both LMP1 and IRF7 are high in type III latency (13). It is interesting that even though LMP1 protein is highly expressed in Sav III and Jijoye cell lines in Western blot, there are two patterns of IRF7 expression in Jijoye cells when detected by immunofluorescence staining. Liebowitz et al. reported that about 2% of the Jijoye cells showed evidence of early or late viral replication (3). Therefore, some of Jijoye cells are not actually type III latency cells and they do not express LMP1. Not only Jijoye, we found that some of Sav III and Raji cells also did not express LMP1 in immunofluorescence staining (data not shown). Cell proliferation also influenced to the EBV replication and interferons also regulate the expression of interferon regulatory factor 7 (25). Those viral or cellular factors may be involved in the induction and/or activation of IRF7 protein. Further experiments will be necessary to confirm which additional factors are involved in the regulation of IRF7.
###end p 31
###begin p 32
###xml 118 124 118 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 188 194 188 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 668 674 668 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 730 737 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4B</xref>
###xml 604 607 <span type="species:ncbi:10376">EBV</span>
In double immunofluorescence staining, colocalization of LMP1 and IRF7 was detected in the cytoplasm of Jijoye cells (Fig. 2) and interaction was also confirmed by co-immunoprecipitation (Fig. 3). The functional diversity of such a transcriptional factor is dependent on its modification, such as by phosphorylation and/or interactions with other transcriptional factors that are co-expressed and/or activated in the cell (27). LMP2A also colocalizes in the LMP1 patch, and LMP2A recruits several cellular kinases, which are involved in the B cell signaling pathway (5). LMP1 and IRF7 over-expression in EBV negative DG75 cells showed that they interacted physically (Fig. 4). The reason why the LMP1 detected in the second lane (Fig. 4B upper panel) is may be that over-expressed LMP1 interacts with endogenous IRF7.
###end p 32
###begin p 33
###xml 282 300 <span type="species:ncbi:10376">Epstein-Barr virus</span>
These results suggest that interaction between LMP1 and IRF7 may be necessary for the signal transduction pathway of LMP1 and/or IRF7. Further experiments will be needed in order to provide additional details about the relationship between LMP1 and IRF7 in the signaling pathway of Epstein-Barr virus infected B-lymphocytes.
###end p 33
###begin p 34
###xml 51 89 51 89 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lineberger Comprehensive Cancer Center</funding-source>
###xml 93 121 93 121 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">University of North Carolina</funding-source>
This work was supported by Dr. Joseph S. Pagano in Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, U.S.A.
###end p 34
###begin article-title 35
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
###end article-title 35
###begin article-title 36
###xml 30 48 <span type="species:ncbi:10376">Epstein-Barr virus</span>
A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection
###end article-title 36
###begin article-title 37
###xml 77 95 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
###end article-title 37
###begin article-title 38
###xml 9 27 <span type="species:ncbi:10376">Epstein-Barr virus</span>
A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
###end article-title 38
###begin article-title 39
###xml 3 21 <span type="species:ncbi:10376">Epstein-Barr virus</span>
An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
###end article-title 39
###begin article-title 40
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus latent membrane protein 1: structure and functions
###end article-title 40
###begin article-title 41
The growing family of interferon regulatory factors
###end article-title 41
###begin article-title 42
Involvement of the IRF-1 transcription factor in antiviral responses to interferons
###end article-title 42
###begin article-title 43
Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes
###end article-title 43
###begin article-title 44
Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2
###end article-title 44
###begin article-title 45
Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
###end article-title 45
###begin article-title 46
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction
###end article-title 46
###begin article-title 47
###xml 58 76 <span type="species:ncbi:10376">Epstein-Barr virus</span>
IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency
###end article-title 47
###begin article-title 48
Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes
###end article-title 48
###begin article-title 49
Multiple regulatory domains control IRF-7 activity in response to virus infection
###end article-title 49
###begin article-title 50
Triggering the interferon antiviral response through an IKK-related pathway
###end article-title 50
###begin article-title 51
###xml 45 63 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1
###end article-title 51
###begin article-title 52
###xml 47 65 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7
###end article-title 52
###begin article-title 53
###xml 55 73 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit
###end article-title 53
###begin article-title 54
###xml 59 77 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit
###end article-title 54
###begin article-title 55
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75)
###end article-title 55
###begin article-title 56
###xml 3 21 <span type="species:ncbi:10376">Epstein-Barr virus</span>
An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA
###end article-title 56
###begin article-title 57
###xml 49 67 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 69 72 <span type="species:ncbi:10376">EBV</span>
Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line
###end article-title 57
###begin article-title 58
###xml 44 62 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 64 67 <span type="species:ncbi:10376">EBV</span>
###xml 168 171 <span type="species:ncbi:10376">EBV</span>
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
###end article-title 58
###begin article-title 59
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
###end article-title 59
###begin article-title 60
Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3
###end article-title 60
###begin article-title 61
Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain
###end article-title 61
###begin article-title 62
Transcriptional activation: a complex puzzle with few easy pieces
###end article-title 62
###begin p 63
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 255 256 255 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 294 295 294 295 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 297 298 297 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 144 150 <span type="species:ncbi:9986">rabbit</span>
###xml 207 213 <span type="species:ncbi:9793">donkey</span>
###xml 219 225 <span type="species:ncbi:9986">rabbit</span>
The immunofluorescence pattern of endogenous IRF7 in various B lymphoblastoid cell lines. Immunofluorescence assays (IFA) were performed with a rabbit polyclonal IRF7 antibody, with subsequent reaction with donkey anti-rabbit IgG-FITC in DG75 (A), Akata (B), Sav I (C), Sav III (D) and Jijoye (E, F) cell lines. IRF7 was captured with a Axioscope fluorescence microscope using a Scion software program.
###end p 63
###begin p 64
###xml 274 275 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 282 283 282 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 298 299 298 299 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 125 131 <span type="species:ncbi:9986">rabbit</span>
###xml 188 194 <span type="species:ncbi:9793">donkey</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 224 230 <span type="species:ncbi:9793">donkey</span>
###xml 236 242 <span type="species:ncbi:9986">rabbit</span>
Colocalization of LMP1 and IRF7. The LMP1 and IRF7 proteins are double immunostained with mouse monoclonal LMP1 antibody and rabbit polyclonal IRF7 antibody, and subsequently reacted with donkey anti-mouse IgG-rhodamine and donkey anti-rabbit IgG-FITC, respectively. Panel (A) and (B) are Jijoye, (C) is Sav III, and (D) is DG75 cell line co-transfected with LMP1 and IRF7 plasmids. Fluoresecence was captured with a confocal microscope. Red and green color represent of LMP1 and IRF7, respectively; yellow indicates colocalization of both proteins.
###end p 64
###begin p 65
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 175 181 <span type="species:ncbi:9986">rabbit</span>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 363 369 <span type="species:ncbi:9986">rabbit</span>
In vivo association of LMP1 with IRF7 in Jijoye. Cell lysates of Jijoye were subjected to immunoprecipitation with normal mouse serum (lane 1), LMP1 antibody (lane 2), normal rabbit serum (lane 3), or IRF7 antibody (lane 4). The immunocomplexes were analyzed by SDS-PAGE on 10% gel and subjected to western blot analysis with mouse LMP1 antibody (upper panel) or rabbit IRF7 antibody (lower panel).
###end p 65
###begin p 66
###xml 231 232 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 252 253 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 304 309 <span type="species:ncbi:10090">mouse</span>
###xml 342 348 <span type="species:ncbi:9986">rabbit</span>
Interaction of LMP1 and IRF7 in transfected DG75. DG75 cells were transfected with pcDNA3 (lane 1), FLAG-pcLMP1 (lane 2), pcIRF7 (lane 3) or FLAG-pcLMP1 plus pcIRF7 (lane 4). Cell lysates were immunopurified with M2 FLAG antibody (A) or IRF7 antibody (B) and then subjected to western blot analysis with mouse LMP1 antibody (upper panels) or rabbit IRF7 antibody (lower panels).
###end p 66

